Assyro AI

Orange Book product · Generic (ANDA)

GRANISETRON HYDROCHLORIDE

GRANISETRON HYDROCHLORIDE

Generic (ANDA)ANDA 091137TE APRX MYLAN ASI

At a glance

Apr 09, 2010

Approved

Generic (ANDA)

Application

AP

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 09, 2010

    16 yr 5 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

GRANISETRON HYDROCHLORIDE

Strength

EQ 4MG BASE/4ML (EQ 1MG BASE/ML)

Dosage form

INJECTABLE

Route

INJECTION

TE code

AP

Application

ANDA 091137

Product number

002

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of GRANISETRON HYDROCHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.